-
Mashup Score: 5European Commission approves first twice-yearly HIV medication - 2 year(s) ago
This week the European Commission became the first regulatory agency to approve Gilead Sciences’ long-acting HIV capsid inhibitor lenacapavir, to be marketed as Sunlenca. The twice-yearly antiretroviral is indicated for treatment-experienced people with multidrug-resistant HIV who cannot otherwise construct a fully suppressive regimen. Lenacapavir has also shown promise for first-line treatment…
Source: aidsmap.comCategories: HIV/AIDS, Latest HeadlinesTweet
-
Mashup Score: 1IAS – International AIDS Society - 2 year(s) ago
Founded in 1988, the International AIDS Society (IAS) is the world’s largest association of HIV professionals, with members from more than 180 countries working on all fronts of the global AIDS response. The IAS is also the steward of the world’s two most prestigious HIV conferences – the International AIDS Conference and the IAS Conference on HIV Science.
Source: YouTubeCategories: HIV/AIDS, Latest HeadlinesTweet-
Accede a la ciencia de #IAS2021 sobre coinfecciones, comorbilidades, prevención, tratamiento y vacuna del #VIH en árabe, español, francés, portugués y ruso. ¡Ayude a difundir la ciencia compartiendo este contenido en sus redes! https://t.co/wMpSddT7Wm https://t.co/M0OHao2azj
-
-
Mashup Score: 0IAS – International AIDS Society - 2 year(s) ago
Founded in 1988, the International AIDS Society (IAS) is the world’s largest association of HIV professionals, with members from more than 180 countries working on all fronts of the global AIDS response. The IAS is also the steward of the world’s two most prestigious HIV conferences – the International AIDS Conference and the IAS Conference on HIV Science.
Source: YouTubeCategories: HIV/AIDS, Latest HeadlinesTweet-
Accédez à la science de #IAS2021 sur les co-infections, les comorbidités, la prévention, le traitement et le vaccin du #VIH avec sous-titres de arabe, espagnol, français, portugais et russe. https://t.co/wMpSddT7Wm https://t.co/mGz9EMnfPc
-
-
Mashup Score: 0IAS – International AIDS Society - 2 year(s) ago
Founded in 1988, the International AIDS Society (IAS) is the world’s largest association of HIV professionals, with members from more than 180 countries working on all fronts of the global AIDS response. The IAS is also the steward of the world’s two most prestigious HIV conferences – the International AIDS Conference and the IAS Conference on HIV Science.
Source: YouTubeCategories: HIV/AIDS, Latest HeadlinesTweet-
Want to learn more about #HIV prevention, treatment, and potential vaccines? #FollowtheScience and access free videos from #IAS2021 subtitled in Arabic, French, Portuguese, Russian and Spanish! https://t.co/wMpSddT7Wm https://t.co/FePUZlg2fP
-
-
Mashup Score: 9HIV: The misinformation still circulating in 2021 - 2 year(s) ago
Huge progress has been made in treatment, prevention and understanding of HIV – but falsehoods still hurt people living with it.
Source: BBC NewsCategories: HIV/AIDS, Latest HeadlinesTweet-
People living with HIV who receive treatment can enjoy entirely normal life spans. For #WorldAIDSDay, the @BBC talked to #IAS2021 Young Leader @D_Moraa and others about the devastating impact of HIV misinformation https://t.co/Dkjc8njudT
-
-
Mashup Score: 0Online Resources and Webinars - 2 year(s) ago
Founded in 1988, the International AIDS Society (IAS) is the world’s largest association of HIV professionals, with members from more than 180 countries working on all fronts of the global AIDS response. The IAS is also the steward of the world’s two most prestigious HIV conferences – the International AIDS Conference and the IAS Conference on HIV Science.
Source: www.iasociety.orgCategories: HIV/AIDS, Latest HeadlinesTweet-
Featured presentations from #IAS2021 are now available in Arabic, French, Portuguese, Russian and Spanish on the IAS Educational Fund online resources webpage https://t.co/es6uLpVtVT https://t.co/7v3KZImF9b
-
-
Mashup Score: 1
As noted in my previous post, attending virtual meetings poses some serious challenges. The biggest obstacle: trying to do one’s regular job while periodically checking in (or more likely not checking in) on the meeting. And while I might have been able to pull off some Really Rapid Reviews© after a few virtual meetings, not so […]
Source: HIV and ID ObservationsCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Interesting and Important Studies from IAS 2021 and IDWeek That Caught My Eye - A new HIV and ID Observations post from @PaulSaxMD: https://t.co/M9of1aZz7U #IAS2021 #IDWeek2021 https://t.co/K5rBqH4GLl
-
-
Mashup Score: 2What we learned at IAS 2021 - 3 year(s) ago
In the 40 years since AIDS was first reported, nearly 35 million people have died from AIDS-related causes.
Source: iasocietyCategories: HIV/AIDS, Latest HeadlinesTweet-
What we learned at #IAS2021. IAS President @ProfAdeeba discusses some of the highlights and key themes which emerged from the 11th IAS Conference on HIV Science in July. Read her summary here: https://t.co/QCs1R8LdHW https://t.co/LhDQPKWY00
-
-
Mashup Score: 7Long-Acting Injectable PrEP Could Be Approved Early Next Year - 3 year(s) ago
Twice-monthly cabotegravir injections may work even better than daily pills for HIV prevention.
Source: POZCategories: HIV/AIDS, Latest HeadlinesTweet-
The US FDA has accepted @ViiVHC's application for a long-acting cabotegravir injection for #HIV pre-exposure prophylaxis (#PrEP) for priority review. This follows results presented at #IAS2021 showing cabotegravir injections to be more effective than pills https://t.co/c2Bnu80b2f
-
-
Mashup Score: 3IAS 2021 website now open access | HTB | HIV i-Base - 3 year(s) ago
The 11th Conference on HIV Science (IAS 2021) held from 18–21 July 2021 is now available online as open access. https://www.ias2021.org/the-programme This includes more than 150 webcast presentations, 40 satellite sessions and 600 posters. The original links used during the conference to abstracts, sessions and PDF files are still active. However, the original links to individual…
Source: i-base.infoCategories: HIV/AIDS, Latest HeadlinesTweet-
RT @HIViBase: Conference reports: #IAS2021 Website now open access. https://t.co/kW0qaIgQIn @ukcab @4Mproject @Positively_UK @SophiaForu…
-
The European Commission (EC) has approved lenacapavir, a "twice-yearly antiretroviral...for treatment-experienced people w/ multidrug-resistant #HIV". Research on this drug was shared at #IAS2021 & the EC becomes 1st regulatory agency to approve its use. https://t.co/BMv6jxoOQl